【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 What Is This Report About? 8
2.2 Syringes and Needles Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 9
3 Syringes and Needles Market, North America 10
3.1 Syringes and Needles Market, North America, Revenue ($m), 2007-2021 10
3.2 Syringes and Needles Market, North America, Revenue ($m), 2007-2014 12
3.3 Syringes and Needles Market, North America, Revenue ($m), 2014-2021 14
3.4 Syringes and Needles Market, North America, Volume (Units), 2007-2021 16
3.5 Syringes and Needles Market, North America, Volume (Units), 2007-2014 17
3.6 Syringes and Needles Market, North America, Volume (Units), 2014-2021 19
3.7 Syringes and Needles Market, North America, Company Share by Revenue ($m), 2014 21
4 Syringes and Needles Market, Canada 23
4.1 Syringes and Needles Market, Canada, Revenue ($m), 2007-2014 23
4.2 Syringes and Needles Market, Canada, Revenue ($m), 2014-2021 25
4.3 Syringes and Needles Market, Canada, Volume (Units), 2007-2014 27
4.4 Syringes and Needles Market, Canada, Volume (Units), 2014-2021 29
4.5 Syringes and Needles Market, Canada, Average Price ($), 2007-2021 31
4.6 Syringes and Needles Market, Canada, Distribution Share by Revenue ($m), 2013-2014 32
4.7 Syringes and Needles Market, Canada, Company Share by Revenue ($m), 2014 33
5 Syringes and Needles Market, Mexico 35
5.1 Syringes and Needles Market, Mexico, Revenue ($m), 2007-2014 35
5.2 Syringes and Needles Market, Mexico, Revenue ($m), 2014-2021 37
5.3 Syringes and Needles Market, Mexico, Volume (Units), 2007-2014 39
5.4 Syringes and Needles Market, Mexico, Volume (Units), 2014-2021 41
5.5 Syringes and Needles Market, Mexico, Average Price ($), 2007-2021 43
5.6 Syringes and Needles Market, Mexico, Distribution Share by Revenue ($m), 2013-2014 44
5.7 Syringes and Needles Market, Mexico, Company Share by Revenue ($m), 2014 45
6 Syringes and Needles Market, United States 47
6.1 Syringes and Needles Market, United States, Revenue ($m), 2007-2014 47
6.2 Syringes and Needles Market, United States, Revenue ($m), 2014-2021 49
6.3 Syringes and Needles Market, United States, Volume (Units), 2007-2014 51
6.4 Syringes and Needles Market, United States, Volume (Units), 2014-2021 53
6.5 Syringes and Needles Market, United States, Average Price ($), 2007-2021 55
6.6 Syringes and Needles Market, United States, Distribution Share by Revenue ($m), 2013-2014 56
6.7 Syringes and Needles Market, United States, Company Share by Revenue ($m), 2014 57
7 Overview of Key Companies in North America Syringes and Needles Market 59
7.1 Becton, Dickinson and Company 59
7.1.1 Company Overview 59
7.2 B. Braun Melsungen AG 59
7.2.1 Company Overview 59
7.3 Nipro Corporation 59
7.3.1 Company Overview 59
7.4 Baxter International Inc. 60
7.4.1 Company Overview 60
7.5 Smiths Medical 60
7.5.1 Company Overview 60
7.6 Covidien plc 60
7.6.1 Company Overview 60
8 Syringes and Needles Market Pipeline Products 61
9 Recent Developments 62
9.1 Corporate Communications 62
9.1.1 Feb 25, 2016: Sagent Pharmaceuticals Names Frank Harmon Executive Vice President Global Operations 62
9.1.2 Sep 29, 2015: Anacor Pharmaceuticals Announces Presentations of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data at Two Upcoming Medical Conferences 62
9.1.3 Aug 25, 2015: Unilife Appoints Harry Hamill to the Board of Directors 63
9.1.4 Aug 03, 2015: Sagent Pharmaceuticals Board Appoints Allan Oberman as Chief Executive Officer 63
9.1.5 Aug 01, 2015: SPARC Receives Complete Response Letter from USFDA for Latanoprost NDA 64
9.1.6 Jun 03, 2015: Bristol-Myers Squibb to Present Data from 14 Abstracts on Orencia (abatacept) at the European League Against Rheumatism (EULAR) 2015 Annual Meeting 65
9.1.7 Apr 16, 2015: Sagent Pharmaceuticals Appoints Michael Logerfo as President 68
9.1.8 Apr 16, 2015: Shlomo Yanai Joins Sagent Pharmaceuticals Board of Directors 68
9.1.9 Apr 08, 2015: Unilife Appoints Dr. Richard Beckman as Chief Medical Officer 69
9.1.10 Mar 26, 2015: Sagent Pharmaceuticals Announces Leadership Changes 69
9.2 Financial Announcements 70
9.2.1 Feb 16, 2016: Sagent Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Results 70
9.2.2 Feb 09, 2016: Unilife Announces Financial Results For the Second Quarter of Fiscal Year 2016 73
9.2.3 Feb 03, 2016: BD Announces Results For 2016 First Fiscal Quarter 73
9.2.4 Nov 09, 2015: Unilife Announces Financial Results For the First Quarter of Fiscal Year 2016 75
9.2.5 Nov 04, 2015: BD Announces Results For 2015 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2016 Guidance 77
9.2.6 Oct 13, 2015: Spring Bank Pharmaceuticals Announces Presentation of Results from Phase I Clinical Trial Supporting the Novel Mechanism of Action of SB 9200 in Patients with Hepatitis C at The Liver Meeting 79
9.2.7 Sep 29, 2015: Motif Announces Presentation of Two Posters on Iclaprim at ID Week 2015 80
9.2.8 Sep 14, 2015: Unilife Corporation Announces Financial Results For the Fourth Quarter and Full Fiscal Year 2015 81
9.2.9 Aug 14, 2015: Retractable Technologies Reports Results as of June 30, 2015 83
9.2.10 Aug 06, 2015: BD Announces Results for 2015 Third Fiscal Quarter and Raises EPS Guidance for Fiscal 2015 85
9.2.11 Aug 04, 2015: Sagent Pharmaceuticals Reports Second Quarter 2015 Financial Results 87
9.2.12 Jul 29, 2015: Hospira Reports Second-Quarter 2015 Results 88
9.2.13 Jul 28, 2015: Centinel Spine Implants Its First STALIF MIDLINE II-Ti Device 89
9.2.14 May 15, 2015: Retractable Technologies Reports Improved Results for the First Quarter 2015 90
9.2.15 May 11, 2015: Unilife Announces Financial Results For Fiscal Year 2015 Third Quarter 91
9.2.16 May 07, 2015: BD Announces Results For 2015 Second Fiscal Quarter 92
9.2.17 May 05, 2015: Sagent Pharmaceuticals Reports First Quarter 2015 Financial Results 93
9.2.18 Apr 28, 2015: Hospira Reports First-Quarter 2015 Results 94
9.2.19 Apr 27, 2015: Medtronic Announces Consent Decree with FDA for the Synchromed Drug Infusion System 96
9.2.20 Apr 16, 2015: Arch Therapeutics’ AC5 Compared Favorably vs. Commercially Available Combination Hemostat in Animal Study 97
9.2.21 Apr 07, 2015: Dualis MedTech and ReliantHeart Partner on Fully Implantable TET System for the HeartAssist5 LVAD 98
9.2.22 Apr 01, 2015: Retractable Technologies Reports Results for the Three and Twelve Months Ended December 31, 2014 99
9.3 Legal And Regulatory 100
9.3.1 Jul 23, 2015: Sigma-Aldrich Meets Evolving Quality and Regulatory Needs with ISO 13485 Expansion, Provides Diagnostic Customers with Reliable Critical Raw Materials 100
9.3.2 May 21, 2015: Retractable Technologies Reports Recognition of Payment 101
9.3.3 May 01, 2015: Hospira Statement On FDA’s Final Biosimilar Guidance Documents 101
9.3.4 Apr 27, 2015: Retractable Technologies Announces Amended Final Judgment and Notice of Appeal 102
9.3.5 Apr 21, 2015: Retractable Technologies Announces U.S. Supreme Court Decision – Denial of Writ of Certiorari 102
9.3.6 Apr 17, 2015: Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant 103
9.3.7 Apr 13, 2015: Hope for Greater Access for Patients to Biosimilar Medicines 103
9.4 Other Significant Developments 104
9.4.1 Mar 14, 2016: Unilife Realigns Business Units and Leadership Team 104
9.4.2 Dec 07, 2015: ARxIUM Selects Additional Distributors of RIVA Automated Compounding System for Asia-Pacific Region 105
9.4.3 Nov 03, 2015: Sigma-Aldrich Reports Q3 2015 Sales Of $703 Million And Adjusted Diluted EPS Of $1.00 106
9.4.4 Oct 20, 2015: ARxIUM Selects Silver Wing Asia-Pacific International Medical Technology Company as its Exclusive Distributor of RIVA Automated Compounding System in Mainland China 107
9.4.5 Sep 28, 2015: Esperion Therapeutics Provides Further Updates on ETC-1002 Global Phase 3 Strategy Following Receipt of End-of-Phase 2 Meeting Minutes 108
9.4.6 Sep 15, 2015: BD Named 2015 Outstanding Corporate Innovator Winner by Product Development and Management Association 109
9.4.7 May 07, 2015: Sigma-Aldrich Reports Q1 2015 Sales Of $676 Million And Adjusted Diluted EPS Of $1.06. Declares $0.23 Quarterly Dividend. 109
9.4.8 May 05, 2015: Lucigen Expands Technological Reach with Exclusive Sigma-Aldrich Distribution Agreement 111
9.4.9 Mar 19, 2015: Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche 112
9.4.10 Mar 19, 2015: Roche announces global distribution agreement for its Biochemical Reagents product portfolio with Sigma-Aldrich 112
9.5 Product News 113
9.5.1 Oct 05, 2015: Galil Medical Launches New Family Of Cryoablation Needles 113
9.5.2 Apr 13, 2015: Cadence Announces New LaserSwiss Capability 113
9.6 Strategy And Business Planning 114
9.6.1 Jan 21, 2016: Singularity University and BD Announce Collaboration Dedicated to Address Global Healthcare Challenges 114
9.6.2 Jan 20, 2016: West and Noble Collaborate to Improve Patient Education and Training for Self-Injection Systems 115
9.6.3 Sep 28, 2015: Clinical Data Presented On Binimetinib And Encorafenib In Melanoma 116
9.6.4 Jul 13, 2015: BD Announces Sustainability Goals for 2020 118
9.6.5 Jul 08, 2015: BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 119
9.6.6 May 21, 2015: Cadence Announces Major Expansion of Wisconsin Facility 119
9.6.7 May 18, 2015: Haselmeier Group Announces the Relocation of Haselmeier in the United States 120
9.6.8 May 12, 2015: SAFC Expands Carlsbad, Calif. Facility to Support Commercial-Scale Gene Therapy Production, Testing and Filling 120
9.6.9 Apr 17, 2015: Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 121
9.6.10 Apr 06, 2015: Breakout Labs and Becton, Dickinson and Company Partner to Provide Capital and Expertise to Biomedical Startups 122
10 Appendix 123
10.1 Research Methodology 124
10.1.1 Coverage 124
10.1.2 Secondary Research 124
10.1.3 Primary Research 124
10.1.4 Company Share Analysis 125
10.1.5 Distribution Share Analysis 125
10.2 GlobalData Consulting 125
10.3 Contact Us 125
10.4 Disclaimer 126
【レポート販売概要】
■ タイトル:北米の注射器・注射針市場見通し(~2021)■ 英文:North America Syringes and Needles Market Outlook to 2021
■ 発行日:2016年4月1日
■ 調査会社:GlobalData
■ 商品コード:GDMECR0430DB
■ 調査対象地域:北米
- Chubu Electric Power Co., Inc.:発電所及びSWOT分析2013Chubu Electric Power Co., Inc. - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - sum …
- ジニトロアニソールの世界市場20152,4-Dinitroanisole (CAS 119-27-7) Market Research Report 2015 aims at providing comprehensive data on 2,4-Dinitroanisole market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes 2,4-Dinitroanisole description, covers its application areas, manufacturing methods, patterns. It captures 2,4-Dinitroanisole market trends, pays close attention to 2,4-Dinitroan …
- 射撃練習場の世界市場The shooting ranges market is projected to grow at a CAGR of 8.35% during the forecast period (2015-2020).This report includes the financial analysis of key players in the market, historical market analysis, technology trends, market environment analysis, industry overview, which includes supply chain analysis, value chain analysis, and demand model for the market. The report also includes the key …
- デジタル広告市場:ピュブリシスオムニコムグループVSグーグル・フェイスブック・その他企業(Publicis Omnicom Group vs. Google, Facebook, and others in Digital Advertising)The global advertising market is expected to reach approximately $505 B in 2013, representing a 3.5% growth rate. Digital advertising is the fastest growing segment within advertising, and within that segment, mobile is the fastest growing segment of Internet advertising with a projected 67% growth rate. The merger of advertising giants would have more than 130,000 employees and will represent the …
- Cross Timbers Royalty Trust:石油・ガスの開発・生産動向及びコスト分析– Q1, 2013Cross Timbers Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis – Q1, 2013 Summary Cross Timbers Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an esse …
- ハイダイナミックレンジ(HDR)の世界市場:スマートフォン、カメラ、テレビ、ブルーレイプレーヤー、セットトップボックス、プロジェクター、ノートPC、タブレットMarketsandMarkets estimates the high dynamic range market size to grow from USD 1.82 Billion in 2015 to USD 36.82 Billion by 2022, at a CAGR of 37.0% between 2016 and 2022. This market is driven by factors such as the growing large screen display market with greater resolution and the rise in photography industry. Capturing device products are expected to hold the largest market share and dominate …
- 世界のBIPV(建材一体型太陽光発電)市場分析及び予測(2014-2021)In this latest report on the BIPV markets NanoMarkets is updating is quantitative and qualitative assessments and outlooks for the building integrated photovoltaic market. We have been covering the BIPV market since 2007. In this latest report we examine the latest important technological and market developments as well as the various region specific factors shaping the market. While the last few …
- 貨物管理システムの世界市場予測(~2023年)The freight management system market is expected to grow at a Compound Annual Growth Rate (CAGR) of 10.1% during the forecast periodThe freight management system market size is expected to grow from USD 10.76 billion in 2018 to USD 17.45 billion by 2023, at a CAGR of 10.1% during the forecast period. This growth is expected to be fuelled by the business values, such as the need to reduce the trans …
- Comprehensive Messaging PackageThe Comprehensive Messaging Package is a comprehensive package that includes many reports in the areas of messaging (SMS, MMS, IM, etc.), next generation messaging, SMS Aggregators, and related areas (see Table of Contents for full list). The package includes technology and market analysis, ecosystem and value chain analysis, and will help the reader understand next generation networks and the fut …
- 自動車用カムレス型のエンジンの世界市場2017-2021About Automotive Camless Engine An automotive camless engine is defined as an engine configuration wherein the poppet valves are operated using pneumatic, electrohydraulic, or electromagnetic actuator systems instead of conventional cams. The intake or exhaust valves are operated using the camless arrangement of the camshaft, which incorporates the use of springs or other means. This type of engin …
- 呼吸保護装置(RPE)の世界市場:呼吸マスク、呼吸具About RPE Personal protective equipment are products and accessories that ensure employee safety during on-site and off-site work. RPE is a type of personal protective equipment used in various commercial and industrial sectors to protect employees from contaminants, aerosolized chemicals, and harmful gases. They are also being extensively used by the general population to shield themselves from a …
- OLEDディスプレイの世界市場2017-2021About OLED DisplayOLED is a carbon-based diode, which produces light when electricity is passed through the conductors. OLED is a display technology that provides superior picture quality than LCD. The technology used in OLED display primarily consists of passive and active matrix OLED. Technavio’s analysts forecast the global OLED display market to grow at a CAGR of 21.86% during the period 2017- …
- 建設重機の世界市場2015-2022According to Stratistics MRC, the Global Heavy Construction Equipment Market is valued at $116.48 billion in 2015 and is expected to grow at a CAGR of 7.34% to reach $191.34 billion by 2022. Growth in construction activity is one of the major factors fueling the market growth. Reduction in the cost of labor and time are favoring the market to grow. Economic development and rise in infrastructural …
- ポイントオブケア(PoC)脂質試験の世界市場分析:機器別(ブランド市場規模:ロシュリフロトロン、ロシュコバス b 101、アバクシスピッコロ、アリーアコレステックLDX、サムスンLABGEO、PTSカーディオチェック)、用途別(高脂血症、高トリグリセリド血症、家族性高コレステロール血症、高リポタンパク血症、タンジール病)、動向分析Global Point of care (PoC) Lipid Test market is expected to reach USD 280.02 million by 2022 according to a new report by Grand View Research Inc. Growing geriatric population base, increasing global prevalence of cardiovascular diseases, and rising healthcare awareness due to patient education are the driving forces for the PoC Lipid Test industry growth during the forecast period. Furthermore, c …
- データコンバーターの世界市場2016-2020About the Data Converter Market Data converters are used to convert and condition signals. They are integrated into the device to convert digital to analog and vice versa. The use of data converters in the devices enhances the processing, data transmission, and process control capabilities. These data converters are based on the architectures, which are proprietary architectures of companies such …